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In nuclei of cells infected with herpes simplex virus (HSV), synthesized viral DNA accumulates as concatamers that are
cleaved into genomic lengths and inserted into preformed capsids. Whereas newly replicated DNA and enzymes required for
DNA synthesis accumulate in sites of infected cell nuclei termed replication compartments, the intranuclear site of DNA
cleavage and packaging is currently controversial. DNA packaging requires the UL6, UL15, UL17, UL25, UL28, UL32, and UL33
genes in addition to the major capsid proteins. Using confocal immunofluorescence microscopy, it was observed that in
.95% of HEp-2 cells fixed at late times after infection with wild-type HSV-1, capsids, major capsid proteins ICP5 and ICP35,
and the UL6-encoded minor capsid protein localized in DNA replication compartments. These data support the hypothesis
that capsid assembly and DNA cleavage/packaging normally occur in HEp-2 cell replication compartments. In contrast, cells
infected with a viral mutant lacking functional UL17 contained antigenically dense nuclear aggregates that stained with ICP35,
ICP5, and capsid specific antibodies. Cells infected with the UL17 mutant virus also displayed UL6-specific fluorescence in
a diffuse pattern at the nuclear periphery in regions not containing ICP35 and ICP5. Displacement of ICP35 from replication
compartments was not observed in cells infected with cleavage/packaging mutants lacking UL28 and UL33. We conclude that
the UL17 gene is required for correct targeting of capsids and major and minor capsid proteins to the DNA replication
compartment of HEp-2 cells and deduce that this targeting reflects one functional role of UL17 in viral DNA cleavage and
packaging. © 1998 Academic Press
INTRODUCTION
Three types of capsids, designated A, B, and C, accu-
mulate in nuclei of cells infected with herpes simplex
virus (HSV) (Roizman and Furlong, 1974). B capsids con-
sist of an internal core composed of VP22a (or ICP35)
surrounded by an external shell composed largely of
capsomeres of VP5 (or ICP5) linked by triplexes com-
posed of one molecule of VP19C bound to two molecules
of VP23 (Gibson and Roizman, 1972; Cohen et al., 1980;
Newcomb and Brown, 1989; Newcomb et al., 1993, 1996).
A protease (VP24) is also packaged within the core of the
capsid (Gibson and Roizman, 1972; Davison et al., 1992).
The external shells of A, B, and C capsids are identical,
but A and C capsids lack the internal core of B capsids
(Gibson and Roizman, 1972; Schrag et al., 1989; Booy et
al., 1991; Zhou et al., 1994). Only C capsids contain
genomic DNA (Gibson and Roizman, 1972).
Studies of HSV capsid assembly have been reviewed
(Steven and Spear, 1997; Homa and Brown, 1997). In
summary, (i) subunits consisting of VP22a, triplexes, and
VP5 initially assemble in the cytoplasm (Nicholson et al.,
1994; Rixon et al., 1996). (ii) Following nuclear importation
of protein complexes, binding of triplexes to neighboring
VP5 molecules and self-association of the scaffold pro-
tein may serve to drive simultaneous assembly of the
inner and outer capsid shells (Newcomb et al., 1996). (iii)
Completion of the outer shell produces a roughly spher-
ical structure termed the procapsid (Trus et al., 1996). It
has been proposed that the procapsid serves as the
precursor of type A, B, and C capsids (Newcomb et al.,
1996). (iv) Maturation of the procapsid to other capsid
types is closely linked to activation of the packaged
protease that cleaves the C-terminal 25 amino acids from
VP22a, freeing the scaffold from the outer shell (Preston
et al., 1983; Liu and Roizman, 1991; DiIanni et al., 1993;
Gao et al., 1994; Matusick-Kumar et al., 1995; Tatman et
al., 1994; Thomsen et al., 1995). Possibly concurrent with
extensive conformational changes resulting in an icosa-
hedral, less porous outer shell, the freed scaffold is
either lost (in A or C capsids) or collapses inwardly to
produce a small internal core (in small-cored B capsids).
Type A capsids result when scaffold expulsion/degrada-
tion is uncoupled from DNA insertion, whereas small-
cored B capsids arise when the scaffold is not expelled
but retained within the icosahedral outer shell. Alterna-
tively, insertion of viral DNA into the procapsid and loss
of the scaffold produces type C capsids which are pref-
erentially enveloped at the inner nuclear membrane to
form virions (Roizman and Furlong, 1974).
The UL6, UL15, UL17, UL28, UL32, and UL33 genes are
1 To whom reprint requests should be addressed. Fax: (607) 253-
3384. E-mail: jdb11@cornell.edu.
VIROLOGY 252, 115–125 (1998)
ARTICLE NO. VY989439
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
115
required for cleavage of concatameric DNA into unit-
length genomes but are dispensable for production of
small-cored B-like capsids. Thus deletion or insertion
mutations in any one of these genes precludes genera-
tion of C capsids presumably because cleaved DNA is
not available for the packaging reaction (Al-Kobaisi et al.,
1991; Tengelsen et al., 1993; Patel et al., 1996; Baines
et al., 1997; Yu et al., 1997; Lamberti and Weller, 1998;
Salmon et al., 1998). The UL25 gene is dispensable for
cleavage of viral DNA but is essential for production of C
capsids (McNab et al., 1998). At least the UL6, UL15, and
UL25 gene products are minor components of B and C
capsids, suggesting that they might serve to link DNA to
the capsid, or mediate DNA insertion (Patel and Mac-
lean, 1995; McNab et al., 1998; Salmon and Baines,
1998). Neither the UL17 nor UL32 gene products have
been detected in B capsids (Lamberti and Weller, 1998;
Salmon et al., 1998). UL17-encoded proteins are incorpo-
rated into virions and are likely associated with the
tegument, a region of the virion between the outer capsid
surface and inner surface of the virion envelope (Salmon
et al., 1998).
Sites of viral DNA synthesis, viral DNA, and enzymes
required for HSV DNA replication localize in a central
region of infected cell nuclei termed the DNA replication
compartment (Quinlan et al., 1984; de Bruyn Kops and
Knipe, 1994; Phelan et al., 1997). The HSV single-
stranded DNA binding protein ICP8 serves as a marker
for this compartment (Quinlan et al., 1984). In Vero cells
early in infection, major capsid proteins and at least
some UL32 gene product localize in the DNA replication
compartment (Lamberti and Weller, 1998). In cells in-
fected with a virus lacking UL32 however, capsids are
displaced from the DNA replication compartment indicat-
ing that viral proteins are required for localization of
capsids within this compartment and suggesting that
this localization is important for DNA cleavage and pack-
aging (Lamberti and Weller, 1998). Later in infection,
major capsid proteins and some tegument proteins often
accumulate in intranuclear regions of Vero cells termed
assemblons, which arise in regions peripheral to the
DNA replication compartment but not abutting the inner
nuclear membrane (Ward et al., 1996). In contrast, UL15-
specific immunofluorescence remains largely within the
DNA replication compartment of Vero cells even late in
infection, indicating that some steps in viral DNA cleav-
age/packaging (e.g., processing of viral DNA) may also
occur in the DNA replication compartment of Vero cells
late in infection (Ward et al., 1996).
The possibility that the UL17 gene products act to
properly target capsids and major and minor capsid
proteins to specific intranuclear sites is addressed in
this study. We determined that unlike in Vero cells, .95%
of HEp-2 cells contain the major capsid proteins ICP5
and ICP35, as well as the UL6-encoded minor capsid
protein, in the DNA replication compartment late in in-
fection. We also show that these capsid proteins no
longer colocalize in the replication compartment in cells
infected with a DNA cleavage/packaging mutant lacking
functional UL17. This suggests that one role of UL17
proteins is to correctly target capsids and proteins re-
quired for capsid assembly to replication compartments,
the likely sites in HEp-2 cells where DNA-containing
capsids are assembled.
RESULTS
Identification of the UL6 protein
As described under Materials and Methods, rabbits
were immunized with an affinity-purified bacterial fusion
protein containing the maltose binding protein fused to
UL6 sequences (MBP-UL6). To determine the specificity
of the antiserum, proteins in lysates of mock-, HSV-1(F)-,
and UL6
2-infected HEp-2 cells were separated on a
denaturing polyacrylamide gel, transferred to a nitrocel-
lulose membrane, and reacted with the antiserum di-
rected against MBP-UL6. Bound antibody was identified
by reaction of the nitrocellulose sheet with alkaline-
phosphatase-conjugated anti-rabbit immunoglobulin fol-
lowed by the fixation of colored substrate as described
(Baines and Roizman, 1993). The anti-MBP-UL6 antibody
recognized a band of 79,000 apparent Mr in HSV-1(F)-
infected lysates (Fig. 1, lane 2). This band was not
present in lysates of cells infected with a virus that
lacked the capacity to produce the last 298 amino acids
of UL6 protein because of a frameshift mutation at codon
378 (Patel et al., 1996) (Fig. 1, lane 3) or lysates of
mock-infected cells (Fig. 1, lane 1). Immunoblotting of
mock-, HSV-1(F)-, and UL6
2 virus-infected cell lysates
with the UL21 polyclonal rabbit antiserum demonstrated
the presence of UL21-specific immunoreactive bands in
lysates of HSV-1(F)- and UL6
2 virus-infected cells (data
FIG. 1. Immunoblot of mock, HSV-1(F)- and UL6
2-infected HEp-2 cell
lysates prepared 18 h p.i. Electrophoretically separated proteins from
lysates of mock-infected or infected cells were transferred to nitrocel-
lulose and probed with antiserum raised against the MBP-UL6 fusion
protein. Molecular weights are indicated in thousands to the left of the
figure. Lane 1, UL6
2-infected cell lysate; lane 2, HSV-1(F)-infected cell
lysate; lane 3, mock-infected cell lysate. The arrow head indicates the
position of the UL6 protein.
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not shown). We therefore conclude that (i) the UL6
2
mutant virus expresses viral proteins and (ii) the anti-
serum directed against MBP-UL6 recognizes the product
of the UL6 open reading frame in infected cell lysates.
To assess the specificity of the indirect immunofluo-
rescent staining with the MBP-UL6 antiserum, cells were
infected with wild-type virus [HSV-1(F)] or the UL6 inser-
tion virus (UL6
2 mutant virus), permeabilized in methanol
at 18 h p.i., and reacted with ICP35-specific monoclonal
antibody and MBP-UL6-specific antiserum. To reduce
possible reactions with host proteins in indirect immu-
nofluorescence assays, the MBP-UL6-specific antiserum
was extensively adsorbed against uninfected HEp-2 cell
lysates in the presence of 1% Tween 20. HSV glycopro-
teins E and I encode an Fc receptor that binds rabbit
immunoglobulin (Johnson et al., 1988). To reduce high
background levels of fluorescence resulting from binding
of antibody to the HSV-encoded Fc receptor, permeabil-
ized cells were reacted extensively with 10–20% human
serum as described under Materials and Methods.
Bound rabbit immunoglobulin was visualized by reaction
with either rhodamine- or Texas Red-conjugated anti-
rabbit immunoglobulin and fluorescein-conjugated anti-
mouse immunoglobulins that displayed minimal reactiv-
ity with human serum (Jackson Immunoresearch), and
cells were viewed in light filtered for excitation of the
appropriate conjugates. The results indicated that al-
though HSV-1(F)-infected cells stained with the MBP-UL6
antiserum demonstrated extensive intranuclear fluores-
cence (described in more detail below), levels of indirect
immunofluorescent staining in cells infected with the UL6
mutant virus (UL6
2; Fig. 2) did not demonstrate extensive
fluorescence in the nucleus or cytoplasm. Although
some fluorescence was present in UL6
2 virus-infected
cells stained with the MBP-UL6 antiserum (Fig. 2), the
intensity of indirect immunofluorescence in cells infected
with the UL6
2 virus was considerably less than that seen
in cells infected with viruses expressing UL6 protein (Fig.
2) and was similar to levels seen in uninfected cells
stained with MBP-UL6 antiserum (not shown). Thus not-
withstanding some background staining attributable to
cross-reactivity with uninfected cell proteins, these data
support the conclusion that the more intense intranu-
clear fluorescence produced upon staining with the
preadsorbed MBP-UL6 antiserum in permeabilized cells
infected with wild-type virus reflects the presence of the
UL6 gene product.
To characterize the distribution of UL6 protein in wild-
type virus infected cells, HEp-2 cells were infected with
the wild-type strain HSV-1(F) and were fixed and perme-
abilized at 18 h after infection in cold methanol. The
permeabilized cells were incubated with MBP-UL6-spe-
cific antiserum and monoclonal antibody directed
against ICP8. Bound antibodies were detected by reac-
tion with Texas Red-conjugated anti-rabbit antibody and
FITC-conjugated anti-mouse antibody. As expected,
ICP8-specific fluorescence accumulated in the nuclei of
infected cells (Fig. 2). The UL6-specific immunofluores-
cence largely colocalized with ICP8-specific fluores-
cence; minor amounts also accumulated in numerous
small punctate regions located peripheral to the ICP8
containing DNA replication compartment. In ;5% of cells
infected with wild-type virus, UL6-specific staining local-
ized within punctate regions peripheral to the DNA rep-
lication compartment that resembled previously de-
scribed assemblons (Ward et al., 1996). A cell that dis-
plays some assemblons can be seen in Fig. 2, third row,
right-most cell. Taken together, these data indicate that
UL6 protein mostly accumulates in the DNA replication
compartment of HEp-2 cells late after infection with wild-
type HSV-1(F) (Fig. 2).
Colocalization of UL6 protein with major capsid
proteins
The next set of experiments was designed to test the
possibility that the UL6-encoded minor capsid protein
colocalized with major capsid proteins late in infection.
At 18 h p.i., HSV-1(F)-infected cells were incubated with
MBP-UL6 antiserum and monoclonal antibody against
ICP5 or ICP35. Rhodamine- or Texas Red-conjugated
anti-rabbit antibody was used to detect bound MBP-UL6,
and FITC-conjugated anti-mouse antibody was used to
detect bound anti-ICP5 or anti-ICP35 antibodies. The
appearance of cells viewed in light appropriate for exci-
tation of the various conjugates revealed that UL6-spe-
cific fluorescence colocalized with both ICP5- and
ICP35-specific fluorescence in an even distribution
throughout infected nuclei (Fig. 2). We conclude that the
major capsid proteins ICP5 and ICP35 colocalize with
UL6 protein late in infection of HEp-2 cells and deduce
that because UL6 protein largely localized in the DNA
replication compartment late in infection, that ICP5 and
ICP35 also accumulate primarily in the DNA replication
compartment late in infection. These data strongly sug-
gest that the replication compartment represents the site
of capsid assembly in HEp-2 cells.
UL17 is required for proper intranuclear localization
of major and minor capsid proteins
To test the possibility that proteins known to be re-
quired for cleavage and packaging might play a role in
localization of capsid proteins in regions of the nucleus
in which DNA cleavage/packaging takes place, we ex-
amined the intranuclear distribution of UL6 protein,
ICP35, and ICP5 in cells infected with available mutant
viruses defective in viral DNA cleavage and packaging.
The patterns of fluorescence in cells infected with the
UL17 mutant [HSV-1 D(UL17)] showed a striking depar-
ture from those of cells infected with wild-type virus and
other cleavage packaging mutants. Specifically, ICP5
and ICP35 fluorescence no longer localized with ICP8 in
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the replication compartment (Fig. 3). Rather, both ICP5-
and ICP35-specific fluorescence accumulated in anti-
genically dense aggregates at the edges of infected cell
nuclei (Fig. 3). UL6-specific fluorescence appeared
somewhat diffuse and no longer colocalized with ICP8-
specific fluorescence (Fig. 3). Additionally, UL6-specific
FIG. 2. Digital confocal images of infected HEp-2 cells fixed and stained at 18 h p.i. Cells were infected with a virus lacking an intact UL6 gene (UL6
2)
or wild-type virus HSV-1(F) (WT) and were reacted with mouse monoclonal antibodies directed against the indicated HSV-1 proteins and rabbit
polyclonal antiserum against UL6-MBP. Bound monoclonal antibodies were visualized with fluorescein isothiocyanate (FITC)- conjugated donkey
antimouse antiserum (green) and polyclonal antibody was visualized with lissamine rhodamine- or Texas Red-conjugated donkey anti-rabbit antibody
(red). Single color images were recorded simultaneously and are shown in the left and middle columns. The right column represents the merged
images of the left and middle panels in each row. Images were recorded with Bio-Rad software and printed on a Codonics NP1600 dye sublimation
printer.
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fluorescence was dissociated from regions exhibiting
ICP5- and ICP35-specific fluorescence (Fig. 3). To con-
firm that the altered staining patterns observed in the
UL17 mutant virus [HSV-1 D(UL17)]-infected cells were
due solely to the defect in the UL17 gene, we examined
the distribution of ICP5 and the UL6 protein in cells
FIG. 3. Digital confocal images of infected HEp-2 cells fixed and stained 18 h after infection. Cells were infected with HSV-1(DUL17), a virus lacking
an intact UL17 gene, and were reacted with monoclonal antibodies against ICP5, ICP35, or ICP8 and polyclonal antiserum against ICP8 or MBP-UL6.
Bound mouse immunoglobulin was visualized with FITC-conjugated donkey anti-mouse immunoglobulin (green) and bound rabbit immunoglobulin
was visualized with Texas Red- or lissamine rhodamine-conjugated donkey anti-rabbit immunoglobulin (red). Single color images in the left and
middle columns were recorded simultaneously or separately. The right column represents the merged images of the left and middle panels in each
row. Images were recorded and printed as described in the legend to Fig. 2.
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infected with a virus bearing a stop codon within the
UL17 gene [HSV-1(UL17-stop)] and a virus derived from
HSV-1(UL17-stop) bearing a restored UL17 gene [HSV-
1(UL17-restored)] (Fig. 4). These viruses have been de-
scribed previously (Salmon et al., 1998). The patterns
observed in cells infected with UL17-stop and UL17-re-
stored (Fig. 4) were similar to those seen in the UL17
deletion virus [HSV-1 D(UL17)] (Fig. 3) and HSV-1(F)-
infected cells (Fig. 2), respectively. Thus reversal of the
mutation in UL17 allowed capsid proteins to distribute
evenly throughout the DNA replication compartment, as
in wild-type virus infected cells. We therefore conclude
that the UL17 gene is required for (i) proper distribution of
ICP5 and ICP35 in the DNA replication compartment and
(ii) colocalization of the minor capsid protein encoded by
UL6 with major capsid proteins ICP5 and ICP35.
In the above experiments, ICP35-specific staining of
intact permeabilized cells is likely due to noncapsid
associated ICP35 inasmuch as capsid associated ICP35
is sequestered in the capsid core (Newcomb and Brown,
1989). Similarly, at least some of the ICP5-specific immu-
nofluorescence represents noncapsid-associated ICP5.
To examine the role of UL17 in distribution of capsids,
cells were infected with HSV-1(F) or the UL17 deletion
mutant [HSV-1 D(UL17)], permeabilized at 18 h after in-
fection, and stained with a monoclonal antibody, 8F,
which specifically recognizes an ICP5 epitope present
only after ICP5 has undergone conformational changes
during maturation of the outer capsid shell (Trus et al.,
1992). The same cells were also stained with an ICP8-
specific polyclonal rabbit antiserum directed against
ICP8 (Shelton et al., 1994). At 18 h p.i., cells stained with
the capsid-specific antibody demonstrated both cyto-
plasmic and nuclear staining. This observation was likely
due to staining of intranuclear capsids and capsids
present within cytoplasmic virions that accumulate in
large numbers at late times after infection (Fig. 5). In-
tranuclear capsid-specific fluorescence colocalized with
ICP8-specific fluorescence, indicating that capsids are
normally evenly distributed in the DNA replication com-
partment (Fig. 5). In contrast to these observations, but
consistent with the appearance of electron micrographs
of UL17 deletion virus-infected cells (Salmon et al., 1998),
capsid-specific fluorescence appeared predominantly in
the nuclei of HEp-2 cells within brightly staining punctate
regions that accumulated at the nuclear periphery in
regions not containing ICP8 (Fig. 5). These data indicate
that (i) intranuclear capsids accumulate primarily in the
DNA replication compartment of HEp-2 cells late in in-
fection with wild-type virus and (ii) the UL17 gene is
required for the normal distribution of capsids within this
compartment.
One possibility to explain these observations is that
aberrant targeting of capsid assembly components re-
flects a consequence of defective DNA cleavage and
packaging rather than a specific role of UL17 gene prod-
ucts in targeting of assembly products to DNA replication
compartments. To address this possibility, cells were
infected with cleavage/packaging mutant viruses lacking
intact UL15 [HSV-1(DUL15ExII)] (Baines et al., 1997) (data
not shown), UL28 (mutant virus gCB) (Fig. 6, UL28
2), and
UL33 (mutant virus UL33
2) (Fig. 6, UL33
2) and were
stained with ICP35-specific mouse monoclonal antibody
and rabbit antiserum directed against MBP-UL6 protein.
The results indicated that fluorescence attributable to
ICP35 and UL6 protein coincided in an even distribution
throughout infected cell nuclei (Fig. 6). Thus colocaliza-
tion of major and minor capsid proteins is dependent on
the UL17 gene but not DNA cleavage and packaging.
Parenthetically, these data also indicate that the colocal-
ization of major and minor capsid proteins occurs in cells
infected with viruses derived from a variety of viral
strains including HSV-1(F) [HSV-1(DUL15ExII)], HSV-1(17)
(UL17-restored), and HSV-1(KOS) (UL28 mutant virus,
gCB).
DISCUSSION
Using confocal immunofluorescence microscopy, we
have determined that the minor capsid protein encoded
by UL6 and major capsid proteins ICP5 and ICP35 pri-
marily localize within the DNA replication compartment
of HEp-2 cells late after infection with wild-type HSV-1(F).
As revealed by staining with a monoclonal antibody
directed against a conformationally sensitive epitope in
capsid-associated ICP5, we have also demonstrated that
capsids localize in replication compartments late in in-
fection of HEp-2 cells. These data, together with the
observation that UL6 protein and major capsid proteins
ICP5 and ICP35 accumulate primarily in the replication
compartment of HEp-2 cells early in infection (not
shown), support the hypothesis that replication compart-
ments are sites of capsid assembly and DNA cleavage
and packaging in HEp-2 cells.
It has been shown that, at least early in infection of
Vero cells, capsids and components required for capsid
assembly accumulate in replication compartments (Lam-
berti and Weller, 1998), whereas later in infection, many
viral assembly components accumulate within regions of
infected Vero cell nuclei, termed assemblons, that accu-
mulate at the periphery of the nucleus outside DNA
replication compartments (Ward et al.,1996). Studies con-
ducted in our laboratory indicated that in Vero cells
infected with HSV-1(F) and stained with capsid-specific
antibodies, assemblons were readily detectable late in
infection (not shown). In contrast to observations in Vero
cells, only 5% of HSV-1(F)-infected HEp-2 cells, fixed and
stained identically as in the studies of Ward et al. (1996),
contained assemblon-like foci as revealed by staining
with antibodies against major capsid proteins and UL6
protein (Fig. 2). The cellular factors that contribute to the
differences in frequency of assemblon formation in
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HEp-2 and Vero cells are unknown. Reasonable expla-
nations include the possibilities that (i) HEp-2 cells pro-
duce fewer capsids or capsid proteins, leading to de-
creased frequency of aggregation of assembly byprod-
ucts, or (ii) HEp-2 cells are more resistant to HSV-
mediated redistribution of intranuclear proteins.
In the absence of the UL17 gene, the distribution of
ICP5 and ICP35 is largely restricted to brightly staining
punctate regions, whereas these proteins are more
evenly distributed throughout the DNA replication com-
partment in HEp-2 cells infected with wild-type virus. The
brightly staining foci in all cells infected with the UL17
mutant were distinguishable from assemblons because
these structures differed in appearance from assem-
blons; the structures occurred more frequently and oc-
casionally were within the DNA replication compartment
(Ward et al., 1996). The minor capsid protein encoded by
UL6 was also displaced in cells infected with the UL17
mutant. Thus in contrast to the appearance of UL6-spe-
cific immunofluorescence that normally colocalizes with
major capsid proteins, UL6 protein accumulated at the
nuclear periphery of cells infected with the UL17 mutant
in sites distinct from replication compartments and re-
gions containing major capsid proteins (Fig. 3). This
mistargeting of UL6 protein does not preclude incorpo-
ration of UL6 protein into capsids inasmuch as the pro-
tein is readily detected in capsids purified from cells
infected with the UL17 mutant (data not shown).
As seen in these indirect immunofluorescence stud-
ies, the absence of the UL17 gene results in the redistri-
bution of capsids from the DNA replication compartment
to aggregates at the nuclear periphery of infected HEp-2
cells. Such aggregates were not present in cells infected
with a virus bearing a restored UL17 gene, indicating that
aberrant distribution of capsid proteins was a conse-
quence of the mutation in UL17. This result is in agree-
ment with previously reported studies in which electron
microscopic examination of UL17 mutant virus-infected
Vero cells revealed intranuclear aggregates of capsids
that accumulated near the inner nuclear membrane late
in infection (Salmon et al., 1998). Electron microscopic
examination of cells infected with a virus derived from a
UL17 insertion mutant and bearing a restored UL17 gene
and of complementing cells infected with UL17 mutants
did not contain capsid aggregates to any appreciable
extent (Salmon et al., 1998). We have also shown in
studies reported herein that capsid proteins remain in
replication compartments in cells infected with DNA
cleavage/packaging mutants lacking functional UL28,
UL33 (Fig. 6), and UL15 (not shown). These observations
indicate that the unusual intranuclear distribution of cap-
sids in cells infected with the UL17 mutant is a result of
the absence of the UL17 gene products rather than a
generic consequence of defective cleavage and packag-
ing.
Paracrystalline arrays of capsids have been observed
in thin sections of nuclei late in infection with wild-type
virus, and these superficially resemble capsid aggre-
gates seen in cells infected with the UL17 mutant (Roiz-
man and Sears, 1995). However, whereas capsid aggre-
gates in wild-type virus-infected cells are relatively un-
common, all capsids in thin sections of cells infected
with the UL17 mutant virus were present in capsid ag-
gregates (Salmon et al., 1998). Data supporting the dif-
ferences in distribution of capsids in wild-type and UL17
mutant virus includes the even distribution of staining
with hexon-specific antibody in wild-type virus-infected
cells, as opposed to the brightly staining punctate re-
gions detected in cells infected with the UL17 mutant
virus (Fig. 5).
The appearance of capsid distribution in cells infected
with the UL17 mutant superficially resembles that of cells
infected with a virus bearing a temperature-sensitive
mutation in the HSV protease and held at nonpermissive
temperatures (Preston et al., 1983; Gao et al., 1994; Wil-
son and Church, 1997). Such cells contain aggregated
procapsids that disperse after induction of capsid matu-
ration upon shift to the permissive temperature (Wilson
and Church, 1997). Although these considerations sug-
gest that UL17 may act to couple capsid maturation to
capsid transport, it is not yet clear that the procapsid
aggregates in cells infected with protease mutants re-
flects the distribution of procapsids in cells infected with
UL17 mutant viruses. In any case, the role that UL17 plays
in capsid trafficking is apparently different from that of
the UL32 gene product given the observation that capsid
aggregates are not readily detected in cells infected with
a viral mutant lacking UL32 (Lamberti and Weller, 1998).
Taken together, the data reported herein suggest that
one role of UL17 proteins is to mediate distribution of
capsid precursors and capsids throughout the DNA rep-
lication compartment where capsids are assembled and
DNA is packaged. Defining the precise role of UL17 in
these processes and how such targeting is mediated
and regulated will require additional studies.
MATERIALS AND METHODS
Cells and viruses
Vero cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 5% newborn
calf serum, penicillin and streptomycin. HEp-2 cells and
all other cell lines used in these studies were maintained
in DMEM supplemented with antibiotics and 10% new-
born calf serum. The following viruses were used in this
study: HSV-1(F) (wild-type virus) (Ejercito et al., 1968), UL6
2
(UL6 mutant virus derived from HSV-1 strain 17) (Patel et
al., 1996), HSV-1(DUL17) [UL17 mutant virus derived from
HSV-1(F)] (Salmon et al., 1998), HSV-1(UL17-stop) (UL17
mutant virus derived from HSV-1 strain 17) (Salmon et al.,
1998), HSV-1(UL17-restored) [UL17-stop mutant virus de-
rived from HSV-1(UL17-stop) bearing a restored UL17
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gene] (Salmon et al., 1998), gCB (UL28 mutant virus
derived from HSV-1 strain KOS) (Tengelsen et al., 1993),
UL33
2 (UL33 mutant virus derived from HSV-1 strain 17)
(Cunningham and Davison, 1993), and HSV-1(DUL15ExII)
[UL15 mutant virus derived from HSV-1(F)] (Baines et al.,
1997). The transformed cell lines G33, G5 (kindly pro-
vided by Dr. Arvind Patel, MRC Virology Unit, Glasgow),
and C1 (kindly provided by Dr. Fred Homa, Pharmacia-
Upjohn) were used for propagation of the UL6, UL33, and
UL28 mutants, respectively. These cell lines have been
described previously (Cunningham and Davison, 1993;
Tengelsen et al., 1993; Patel et al., 1996).
Antibodies
Monoclonal antibodies against HSV-1 ICP8 (GIRC No.
1115), ICP5 (GIRC No. 1117), and ICP35 (GIRC No. 1102)
were purchased from Goodwin Institute for Cancer Re-
search (Plantation, FL). The hexon specific monoclonal
antibody, 8F, was a kind gift from Dr. Min Gao, Bristol-
Myers Squibb, and has been described previously (Trus
et al., 1992). The rabbit polyclonal antibody against ICP8
was a kind gift of Dr. William Ruyechan, State University
of New York at Buffalo, Buffalo, NY, and has also been
described (Shelton et al., 1994). The rabbit polyclonal
antibody against UL21 has been described (Baines et al.,
1994).
Antiserum production and Immunoblotting
To produce an antiserum directed against UL6-en-
coded protein, a SalI fragment containing bases 16,264–
17,324 of HSV-1 (McGeoch et al., 1988) was ligated into
the SalI site of pMal-c (New England Biolabs, Inc., Bev-
erly, MA). This plasmid was predicted to encode the
C-terminal 298 amino acids of UL6 fused to the gene
encoding maltose-binding protein (MBP). The junction of
the two genes was sequenced to ensure that the open
FIG. 4. Digital confocal images of infected HEp-2 cells fixed and stained 16 h p.i. Cells were infected with a virus bearing a stop codon in the UL17
gene HSV-1(UL17-stop) (designated UL17
2) and a virus derived from HSV-1(UL17-stop) but containing a restored UL17 gene [HSV-1(UL17-restored)]
(designated UL17R in the figure). Cells were permeabilized in cold methanol and reacted with monoclonal antibodies against ICP5 and ICP8 and
polyclonal antibodies against ICP8 and MBP-UL6. Monoclonal antibodies were visualized with FITC-conjugated donkey antimouse immunoglobulin
(green). Polyclonal antibodies were detected with Texas Red-conjugated donkey anti-rabbit immunoglobulin (red). Single color images in the left and
middle columns were recorded simultaneously. The right column represents the merged images of the left and middle panels of each row. Images
were recorded and printed as described in the legend to Fig. 2.
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reading frame encoding the fusion protein was main-
tained (not shown). Expression of the soluble fusion
protein (MBP-UL6) was induced by the addition of IPTG to
a final concentration of 0.1 mM, and MBP-UL6 was puri-
fied by affinity chromatography on amylose beads (New
England Biolabs, Inc.). The purified protein was eluted in
10 mM maltose and was used to immunize New Zealand
White rabbits as previously described (Baines and Roiz-
FIG. 5. Digital confocal images of infected HEp-2 cells fixed and stained 18 h p.i. Cells were infected with wild-type HSV-1(F) virus (WT) or
HSV-1(DUL17) (UL17
2) and fixed cells were reacted with a hexon-specific monoclonal antibody (8F) and a polyclonal antibody directed against ICP8.
Monoclonal antibody was visualized with FITC-conjugated donkey antimouse immunoglobulin (green). Bound anti-ICP8 antibody was identified with
Texas Red-conjugated donkey anti-rabbit immunoglobulin (red). Single color images in the left and middle columns were recorded simultaneously.
The right column represents the merged images of the left and middle panels of each row. Images were recorded and printed as described in the
legend to Fig. 2.
FIG. 6. Digital confocal images of HEp-2 cells infected with UL28 mutant (gCB) (UL28
2) or UL33 mutant (UL33
2) viruses and fixed and stained 18 h
after infection. Cells were reacted with monoclonal antibody against ICP35 and polyclonal antiserum against MBP-UL6. ICP35-specific antibody was
visualized with FITC-conjugated donkey anti-mouse antibody (green) and MBP-UL6-specific antibody was visualized with Texas Red-conjugated
donkey anti-rabbit immunoglobulin (red). Single color images in the left and middle columns were recorded simultaneously. The right column
represents the merged image of the left and middle panels in each row. Images were recorded and printed as described in Fig. 2.
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man, 1993). Mock-, HSV-1(F)-, and UL6
2-infected HEp-2
cell lysates were prepared 18 h p.i. in phosphate-buff-
ered saline (PBS), pH 7.4, supplemented with 1% Triton
X-100, 1% sodium deoxycholate, 10 mM TPCK (tolylsulfo-
nyl phenylalanyl chloromethyl ketone) and 10 mM TLCK
(a-tosyl-L-lysine chloromethyl ketone) and separated on
a 7.5% SDS–polyacrylamide gel. Proteins were trans-
ferred to nitrocellulose, and immunoblotting was per-
formed as described (Baines and Roizman, 1993) except
that the MBP-UL6 antiserum was diluted 1:1000 in PBS
plus 1% bovine serum albumin (BSA) and 1% Tween 20.
Immunoblotting with the UL21 antibody was performed
as previously described (Baines et al., 1994).
Confocal immunofluorescence microscopy
Lab-Tek chamber slides (Nunc) were seeded with
30,000 HEp-2 cells per 1.0 cm2 well, or six-well dishes
containing sterile glass cover slips were seeded with
50,000 HEp-2 cells per 10 cm2 well. Cells were allowed
to grow overnight and were infected with various viruses
as indicated in the text. At 18 h p.i., cells were perme-
abilized in ice-cold methanol for 10 min and air dried.
Permeabilized cells were incubated with PBS containing
10–20% human serum (Sigma, S 2145) and 1% BSA to
block nonspecific binding of rabbit immunoglobulin by
the HSV-encoded Fc receptor containing gE/gI (Johnson
et al., 1988). Cells were reacted for 1–2 h at 37°C with
diluted ascites fluid containing antibodies directed
against ICP8 (1:500), ICP5 (1:1000), ICP35 (1:100), and the
anti-MBP-UL6 antiserum, which was extensively ad-
sorbed against HEp-2 cells and diluted 1:50 in PBS plus
1% BSA. Alternatively, cells were incubated with poly-
clonal rabbit antiserum directed against ICP8 (1:1000)
and monoclonal antibodies directed against ICP5, cap-
sid-associated ICP5 (8F, 1:30), or ICP35. After extensive
washing in PBS, cells were incubated with fluorescein
isothiocyanate (FITC)-conjugated donkey anti-mouse im-
munoglobulin and lissamine rhodamine- or Texas Red-
conjugated donkey anti-rabbit immunoglobulin (Jackson
ImmunoResearch Laboratories, Inc.) for 1 h at 37°C.
Samples were washed in PBS and mounted in Vect-
ashield Mounting Medium (Vector Laboratories, Inc.,
Burlingame, CA). Confocal microscopy was done as pre-
viously described (Nalwanga et al., 1996). Digital images
were printed on a Codonics NP1600 dye sublimation
printer.
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